Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Seneca

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Nuclear Medicine and Biology|April 2, 2013
Palladium mediated ¹¹C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [¹¹C]AZD9272Jan D Andersson, Nicholas Seneca, Phong Truong, et al.
Synapse (New York, N.Y.)|January 18, 2006
Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]racloprideNicholas Seneca, Sjoerd J Finnema, Lars Farde, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB)Qian Li, Li Ma, Robert B Innis, et al.
Nuclear Medicine and Biology|March 30, 2010
Effects of ketoconazole on the biodistribution and metabolism of [11C]loperamide and [11C]N-desmethyl-loperamide in wild-type and P-gp knockout miceNicholas Seneca, Sami S Zoghbi, H Umesha Shetty, et al.
Nuclear Medicine Communications|June 23, 2004
Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primatesDnyanesh N Tipre, Masahiro Fujita, Frederick T Chin, et al.
Nuclear Medicine and Biology|August 21, 2007
Brain and whole-body imaging in nonhuman primates with [11C]MeS-IMPY, a candidate radioligand for beta-amyloid plaquesNicholas Seneca, Lisheng Cai, Jeih-San Liow, et al.
Synapse (New York, N.Y.)|March 26, 2010
Dopamine beta-hydroxylase-deficient mice have normal densities of D(2) dopamine receptors in the high-affinity state based on in vivo PET imaging and in vitro radioligand bindingMette Skinbjerg, Nicholas Seneca, Jeih-San Liow, et al.
Psychopharmacology|August 10, 2006
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2Nicholas Seneca, Balázs Gulyás, Andrea Varrone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2012
Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugsAnne Roivainen, Sannamari Hautaniemi, Timo Möttönen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2025
Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear PalsyAndrea Quattrone, Nicolai Franzmeier, Hans-Jürgen Huppertz, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Nuclear Medicine and Biology|April 2, 2013
Palladium mediated ¹¹C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [¹¹C]AZD9272Jan D Andersson, Nicholas Seneca, Phong Truong, et al.
Synapse (New York, N.Y.)|January 18, 2006
Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]racloprideNicholas Seneca, Sjoerd J Finnema, Lars Farde, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB)Qian Li, Li Ma, Robert B Innis, et al.
Nuclear Medicine and Biology|March 30, 2010
Effects of ketoconazole on the biodistribution and metabolism of [11C]loperamide and [11C]N-desmethyl-loperamide in wild-type and P-gp knockout miceNicholas Seneca, Sami S Zoghbi, H Umesha Shetty, et al.
Nuclear Medicine Communications|June 23, 2004
Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primatesDnyanesh N Tipre, Masahiro Fujita, Frederick T Chin, et al.
Nuclear Medicine and Biology|August 21, 2007
Brain and whole-body imaging in nonhuman primates with [11C]MeS-IMPY, a candidate radioligand for beta-amyloid plaquesNicholas Seneca, Lisheng Cai, Jeih-San Liow, et al.
Synapse (New York, N.Y.)|March 26, 2010
Dopamine beta-hydroxylase-deficient mice have normal densities of D(2) dopamine receptors in the high-affinity state based on in vivo PET imaging and in vitro radioligand bindingMette Skinbjerg, Nicholas Seneca, Jeih-San Liow, et al.
Psychopharmacology|August 10, 2006
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2Nicholas Seneca, Balázs Gulyás, Andrea Varrone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 12, 2012
Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugsAnne Roivainen, Sannamari Hautaniemi, Timo Möttönen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2025
Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear PalsyAndrea Quattrone, Nicolai Franzmeier, Hans-Jürgen Huppertz, et al.
Pageof 4